Qureight is a company specializing in precision medicine through the utilization of AI-enabled data curation to accelerate drug development. The company works with biopharma organizations, contract research organizations, and hospitals, focusing on lung and heart diseases. Qureight uses a comprehensive technology stack that enables collaborative analysis across imaging, clinical data, and biomarkers, and employs machine learning algorithms for improved decision-making in drug development processes. Their innovative AI-based platform analyzes complex healthcare data, including clinical trial images and physiological data, to uncover insights that aid in efficient drug approval processes. Qureight collaborates with global healthcare institutions to harness real-world data, providing pharmaceutical clients with structured data in real time. The company’s technology includes AI-powered workflows and image analysis, with applications in areas like interstitial lung diseases, pulmonary hypertension, and lung cancer. Qureight's work is supported by partnerships with key opinion leaders and complies with various industry standards and regulations.